歡迎光臨源葉生物,登錄 | 注冊(cè) |
當(dāng)前位置: 首頁(yè) > 小分子抑制劑 > GPCR/GProtein > AM095 (free acid)

瀏覽歷史

S82467

AM095 (free acid)

源葉(MedMol) ≥98%
  • 英文名:
  • AM095 (free acid)
  • 別名:
  • [4'-[3-甲基-4-[[[((R)-1-苯基乙基)氧基]羰基]氨基]異惡唑-5-基]聯(lián)苯-4-基]乙酸;(R)-2-(4'-(3-methyl-4-((1-phenylethoxy)carbonylamino)isoxazol-5-yl)biphenyl-4-yl)acetic acid; CS-1129; AM095; AM-095 free base; AM095 (free acid);
  • CAS號(hào):
  • 1228690-36-5
  • 分子式:
  • C27H24N2O5
  • 分子量:
  • 456.4899
品牌貨號(hào)產(chǎn)品規(guī)格價(jià)格(RMB) 庫(kù)存(上海) 北京 武漢 南京 數(shù)量計(jì)量單位 加入購(gòu)物車(chē)...
源葉(MedMol) S82467-5mg ≥98% ¥132.00元 6 - - - EA 加入購(gòu)物車(chē)
源葉(MedMol) S82467-10mg ≥98% ¥235.00元 6 - - - EA 加入購(gòu)物車(chē)
源葉(MedMol) S82467-25mg ≥98% ¥451.00元 4 - - - EA 加入購(gòu)物車(chē)
源葉(MedMol) S82467-50mg ≥98% ¥797.00元 3 - - - EA 加入購(gòu)物車(chē)
源葉(MedMol) S82467-100mg ≥98% ¥1331.00元 1 - - - EA 加入購(gòu)物車(chē)
大包裝詢價(jià)

提交您的電話號(hào)碼并同意《個(gè)人信息授權(quán)與保護(hù)申明》,到貨后將短信提示。
提交

產(chǎn)品介紹

參考文獻(xiàn)

質(zhì)檢證書(shū)(COA)

摩爾濃度計(jì)算器

相關(guān)產(chǎn)品

  • 提示:詳情請(qǐng)下載說(shuō)明書(shū)。
  • 產(chǎn)品描述: AM095 (free acid) is a potent LPA1 receptor antagonist with IC50 values of 0.98 and 0.73 μM for recombinant human or mouse LPA1 respectively.
  • 靶點(diǎn): IC50: 0.98 μM (human LPA1), 0.73 μM (mouse LPA1);LPAReceptor;?LPLReceptor
  • 體外研究:
    AM095 inhibits the LPA-induced calcium flux of CHO cells stably transfected with human or mouse LPA1. The IC50 for AM095 antagonism of LPA-induced calcium flux of human or mouse LPA1-transfected CHO cells is 0.025 and 0.023 μM, respectively. AM095 reduces LPA-induced vasorelaxation by appr 90% at 10 μM as compared to vehicle control. AM095 inhibits LPA-driven chemotaxis of CHO cells overexpressing mouse LPA1 (IC50=778 nM) and human A2058 melanoma cells (IC50=233 nM)
  • 體內(nèi)研究:
    Pharmacological antagonism of LPA1 with AM095 significantly attenuates bleomycin-induced dermal fibrosis. AM095 has high oral bioavailability and a moderate half-life and is well tolerated at the doses tested in rats and dogs after oral and intravenous dosing. AM095 dose-dependently reduces LPA-stimulated histamine release. AM095 attenuates bleomycin-induced increases in collagen, protein, and inflammatory cell infiltration in bronchalveolar lavage fluid. AM095 decreases kidney fibrosis in a mouse unilateral ureteral obstruction model
  • 參考文獻(xiàn):
    1. Castelino FV, et al. Amelioration of dermal fibrosis by genetic deletion or pharmacologic antagonism of lysophosphatidic acid receptor 1 in a mouse model of scleroderma. Arthritis Rheum. 2011 May;63(5):1405-15 2. Ruisanchez E, et al. Lysophosphatidic acid induces vasodilation mediated by LPA1 receptors, phospholipase C, and endothelial nitric oxide synthase. FASEB J. 2014 Feb;28(2):880-90 3. Swaney, J. S., et al. Pharmacokinetic and pharmacodynamic characterization of an oral lysophosphatidic acid type 1 receptor-selective antagonist. Journal of Pharmacology and Experimental Therapeutics (2011), 336(3), 693-700.
  • 溶解性: soluble  in  DMSO
  • 保存條件: -20°C
  • 配置溶液濃度參考:
    1mg 5mg 10mg
    1 mM 2.191 ml 10.953 ml 21.906 ml
    5 mM 0.438 ml 2.191 ml 4.381 ml
    10 mM 0.219 ml 1.095 ml 2.191 ml
    50 mM 0.044 ml 0.219 ml 0.438 ml
  • 注意:部分產(chǎn)品我司僅能提供部分信息,我司不保證所提供信息的權(quán)威性,僅供客戶參考交流研究之用。
輸入產(chǎn)品批號(hào):

本計(jì)算器可幫助您計(jì)算出特定溶液中溶質(zhì)的質(zhì)量、溶液濃度和體積之間的關(guān)系,公式為:


質(zhì)量 (mg) = 濃度 (mM) x 體積 (mL) x 分子摩爾量 (g/mol)


  • =
    *
    *


源葉所有產(chǎn)品僅用作科學(xué)研究,銷(xiāo)售產(chǎn)品行為均適用于我司網(wǎng)上所列通用銷(xiāo)售條款。